88 related articles for article (PubMed ID: 7977538)
1. Monoclonal antibody FDC-6 exhibits binding to human plasma fibronectin: a caveat for cervicovaginal oncofetal fibronectin testing?
Feinberg RF; Wang CL
Am J Obstet Gynecol; 1994 Nov; 171(5):1302-8. PubMed ID: 7977538
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody X18A4 identifies an oncofetal fibronectin epitope distinct from the FDC-6 binding site.
Feinberg RF; Kliman HJ; Bedian V; Monzon-Bordonaba F; Menzin AW; Wang CL
Am J Obstet Gynecol; 1995 May; 172(5):1526-36. PubMed ID: 7538728
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated changes in glycosylation of fibronectin. Immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies.
Mandel U; Hamilton Therkildsen M; Reibel J; Sweeney B; Matsuura H; Hakomori S; Dabelsteen E; Clausen H
APMIS; 1992 Sep; 100(9):817-26. PubMed ID: 1389100
[TBL] [Abstract][Full Text] [Related]
4. The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma.
Matsuura H; Hakomori S
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6517-21. PubMed ID: 2995969
[TBL] [Abstract][Full Text] [Related]
5. The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide.
Matsuura H; Takio K; Titani K; Greene T; Levery SB; Salyan ME; Hakomori S
J Biol Chem; 1988 Mar; 263(7):3314-22. PubMed ID: 2449438
[TBL] [Abstract][Full Text] [Related]
6. Oncofetal fibronectin in patients with false labor as a predictor of preterm delivery.
Morrison JC; Allbert JR; McLaughlin BN; Whitworth NS; Roberts WE; Martin RW
Am J Obstet Gynecol; 1993 Feb; 168(2):538-42. PubMed ID: 8438924
[TBL] [Abstract][Full Text] [Related]
7. [Reliability of the detection of fetal fibronectin using monoclonal antibody FDC-6].
Pütz I; Winkler M; Rath W
Geburtshilfe Frauenheilkd; 1995 Dec; 55(12):703-6. PubMed ID: 8582591
[TBL] [Abstract][Full Text] [Related]
8. New biomarkers for the prediction of spontaneous preterm labour in symptomatic pregnant women: a comparison with fetal fibronectin.
Liong S; Di Quinzio MK; Fleming G; Permezel M; Rice GE; Georgiou HM
BJOG; 2015 Feb; 122(3):370-9. PubMed ID: 25056135
[TBL] [Abstract][Full Text] [Related]
9. Cervical fetal fibronectin in patients at increased risk for preterm delivery.
Bittar RE; Yamasaki AA; Sasaki S; Zugaib M
Am J Obstet Gynecol; 1996 Jul; 175(1):178-81. PubMed ID: 8694047
[TBL] [Abstract][Full Text] [Related]
10. The presence of fetal fibronectin in the cervicovaginal secretions of women at term--its role in the assessment of women before labor induction and in the investigation of the physiologic mechanisms of labor.
Blanch G; Oláh KS; Walkinshaw S
Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):262-6. PubMed ID: 8572018
[TBL] [Abstract][Full Text] [Related]
11. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery.
Lockwood CJ; Senyei AE; Dische MR; Casal D; Shah KD; Thung SN; Jones L; Deligdisch L; Garite TJ
N Engl J Med; 1991 Sep; 325(10):669-74. PubMed ID: 1870640
[TBL] [Abstract][Full Text] [Related]
12. Effect of sexual intercourse on fetal fibronectin concentration in cervicovaginal secretions.
Shimoya K; Hashimoto K; Shimizu T; Saji F; Murata Y
Am J Obstet Gynecol; 1998 Jul; 179(1):255-6. PubMed ID: 9704795
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody against human fibronectin which inhibits cell attachment.
Schoen RC; Bentley KL; Klebe RJ
Hybridoma; 1982; 1(2):99-108. PubMed ID: 6208125
[TBL] [Abstract][Full Text] [Related]
14. Cervico-vaginal fetal fibronectin: predictive value during false labor.
Langer B; Boudier E; Schlaeder G
Acta Obstet Gynecol Scand; 1997 Mar; 76(3):218-21. PubMed ID: 9093134
[TBL] [Abstract][Full Text] [Related]
15. The fast-reacting fetal fibronectin test: a screening method for better prediction of the time of delivery.
Ahner R; Kub-Csizi P; Heinzl H; Bikas D; Rabl M; Wagenbichler P; Husslein P
Am J Obstet Gynecol; 1997 Dec; 177(6):1478-82. PubMed ID: 9423754
[TBL] [Abstract][Full Text] [Related]
16. Fetal fibronectin as a marker to predict the onset of term labor and delivery.
Ahner R; Kiss H; Egarter C; Zeillinger R; Eppel W; Karas H; Husslein P
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):134-7. PubMed ID: 7847522
[TBL] [Abstract][Full Text] [Related]
17. Fetal fibronectin in patients at increased risk for premature birth.
Nageotte MP; Casal D; Senyei AE
Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):20-5. PubMed ID: 8296822
[TBL] [Abstract][Full Text] [Related]
18. Synthetic immunochemistry of glycohexapeptide analogues characteristic of oncofetal fibronectin. Solid-phase synthesis and antigenic activity.
Zheng M; Gobbo M; Biondi L; Filira F; Hakomori S; Rocchi R
Int J Pept Protein Res; 1994 Mar; 43(3):230-8. PubMed ID: 8005745
[TBL] [Abstract][Full Text] [Related]
19. Term labor and post-term pregnancy can be predicted using fetal fibronectin (fFN) and IL-lb concentrations in cervicovaginal secretions of pregnant women.
Husslein P; Ahner R
Eur J Obstet Gynecol Reprod Biol; 2002 Sep; 104(2):186. PubMed ID: 12206936
[No Abstract] [Full Text] [Related]
20. Fetal fibronectin as a selection criterion for induction of term labor.
Ahner R; Egarter C; Kiss H; Heinzl K; Zeillinger R; Schatten C; Dormeier A; Husslein P
Am J Obstet Gynecol; 1995 Nov; 173(5):1513-7. PubMed ID: 7503193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
